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Abstract
Background: Postural tremor can sometimes occur in spinocerebellar ataxias (SCAs). However, the prevalence and clinical characteristics of postural tremor in
SCAs are poorly understood, and whether SCA patients with postural tremor have different ataxia progression is not known.
Methods: We studied postural tremor in 315 patients with SCA1, 2, 3, and 6 recruited from the Clinical Research Consortium for Spinocerebellar Ataxias (CRC-SCA),
which consists of 12 participating centers in the United States, and we evaluated ataxia progression in these patients from January 2010 to August 2012.
Results: Among 315 SCA patients, postural tremor was most common in SCA2 patients (SCA1, 5.8%; SCA2, 27.5%; SCA3, 12.4%; SCA6, 16.9%; p 5 0.007). SCA3
patients with postural tremor had longer CAG repeat expansions than SCA3 patients without postural tremor (73.67¡ 3.12 vs. 70.42¡ 3.96, p 5 0.003). Interestingly,
SCA1 and SCA6 patients with postural tremor had a slower rate of ataxia progression (SCA1, b5 –0.91, p, 0.001; SCA6, b5 –1.28, p5 0.025), while SCA2 patients
with postural tremor had a faster rate of ataxia progression (b5 1.54, p5 0.034). We also found that the presence of postural tremor in SCA2 patients could be influenced
by repeat expansions of ATXN1 (b 5 –1.53, p 5 0.037) and ATXN3 (b 5 0.57, p 5 0.018), whereas postural tremor in SCA3 was associated with repeat lengths in
TBP (b 5 0.63, p 5 0.041) and PPP2R2B (b 5 –0.40, p 5 0.032).
Discussion: Postural tremor could be a clinical feature of SCAs, and the presence of postural tremor could be associated with different rates of ataxia progression. Genetic
interactions between ataxia genes might influence the brain circuitry and thus affect the clinical presentation of postural tremor.
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Introduction
Spinocerebellar ataxias (SCAs) are autosomal dominant neurode-
generative disorders involving the cerebellum and related brain struc-
tures.1 While gait disturbance is the predominant feature of SCAs,2
SCA patients often have loss of hand dexterity and coordination. One
such functional impairment is intention tremor, which can be a
disabling symptom for many ataxic patients. The finger–nose–finger
test is part of routine neurological examinations for cerebellar ataxia,
which can be used to detect intention tremor.3
Postural tremor is another form of action tremor. The prototypical
neurological disorder of postural tremor is essential tremor (ET),4 and
pathological alterations in the cerebellum have been identified in ET.5
Postural tremor can be a feature of Holmes tremor resulting from
cerebellar damages as first described by Gordon Holmes.6 These
findings suggest that the cerebellum might be important for postural
tremor generation. Therefore, SCA patients with the degenerative
cerebellum caused by repeat expansion-related protein aggregates
might develop postural tremor.
Among hereditary ataxic disorders, patients with SCA107,8 or
fragile X-associated tremor/ataxia syndrome9 have prominent pos-
tural tremor as the disease hallmark. Postural tremor has been
reported to be present in other forms of SCA patients in several case
reports,10–19 and can also be a prominent feature in CAG-repeat
SCAs,20–23 especially in SCA2.23 However, the sample size in these
studies is moderate (n 5 22–85), and there is no systemic comparison
between SCA patients with and without postural tremor in terms of
genetics and rate of clinical progression.
In the present study, we investigated the prevalence of postural
tremor in SCAs in the Clinical Research Consortium for Spino-
cerebellar Ataxias (CRC-SCA) cohort in North America. We also
studied whether the presence of postural tremor would influence ataxia
progression. Finally, we addressed whether other repeat expansion
genes can be genetic modifiers for postural tremor in SCAs.
Methods
Study subjects
A total of 315 SCA patients (SCA1, 52; SCA2, 69; SCA3, 129;
SCA6, 65) were longitudinally followed every 6 months for 2 years
from January 2010 to August 2012 in the 12 medical centers of the
CRC-SCA. All the participants signed consent forms approved by
their respective local institutional review boards. The inclusion criteria
were 1) definite genetic diagnosis of SCA1, 2, 3, or 6, either for the
subject or for an affected family member with ataxia, 2) willingness of
participation, and 3) age of 6 years and older. The exclusion criteria
were 1) known recessive, X-linked, and mitochondrial ataxias, 2) exclu-
sion of SCA1, 2, 3, and 6 by genetic tests, and 3) concomitant disorders
that affect ataxia measurement used in this study.
All participants received a detailed clinical interview and neuro-
logical examination at baseline, which assessed the presence or absence
of postural tremor by ataxia experts at their respective institutions. All
ataxia specialists were well-trained neurologists and experts in the field
of ataxia and movement disorders. Postural tremor was assessed by
ataxia specialists based on the related maneuver from the Fahn–
Tolosa–Marin tremor rating scale.24 During the neurological exam-
ination, postural tremor was assessed in two maneuvers: forward
horizontal reach posture and lateral ‘‘wing beating’’ posture. Both the
forward horizontal posture and the wing beating posture were held for
10 seconds, respectively. The tremors in both arms were assessed
simultaneously. The presence of postural tremor was defined as the
tremor observed during these maneuvers. The severity of ataxia was
measured by the Scale for Assessment and Rating of Ataxia (SARA),
which constitutes eight different domains of ataxia symptoms. SARA,
an ataxia rating scale that has been used extensively in SCA research,
is a continuous variable (0–40), with higher numbers corresponding
with more severe ataxia.25–27 The presence of intention tremor was
captured by the SARA subscale for the finger–nose–finger test.
Genetic analyses
All CAG repeat numbers of the respective SCA gene were deter-
mined using multiplex polymerase chain reaction, followed by capillary
electrophoresis with internal standards in Dr. Stefan Pulst’s laboratory.
Ten percent of DNA samples were verified using Sanger sequencing.
Additionally, we determined the repeat expansions in ATXN1, ATXN2,
ATXN3, CACNA1A, ATXN7, ATXN10, PPP2R2B, TBP, and FXN, for
which the pathological repeat expansions cause SCA1, SCA2, SCA3,
SCA6, SCA7, SCA10, SCA12, SCA17, and Friedreich’s ataxia,
respectively.
Statistical analyses
We assessed the basic demographics of SCA patients with and
without postural tremor. Chi-square and the Fisher exact test were
used to compare non-continuous variables, testing for normality using
the Kolmogorov–Smirnov test. For normally distributed variables,
we used the Student t-test to compare postural tremor groups with
non-postural tremor groups. For non-normally distributed variables,
we used the Mann–Whitney U-test to compare postural tremor groups
and non-postural tremor groups. A Bonferroni correction was made to
adjust for multiple comparisons; therefore, p , 0.01 was considered
significant in analyses of baseline features between SCA patients with
and without postural tremor (five tests in each SCA).
We treated SCA1, 2, 3, and 6 groups as four independent cohorts.
To study the average rates of disease progression in the SCA groups
with and without postural tremor, we used repeated-measures linear
regression (an exchangeable working within-subject correlation model
by a generalized estimating equation (GEE)). In these models, we
used SARA as the outcome variable, and the presence or absence of
postural tremor at the baseline visit was treated as a dichotomous
variable. We adjusted for age, gender, and CAG repeat expansions in
these models. The ataxia progression of the two groups (postural
tremor vs. non-postural tremor) during the 2-year follow up was
measured by entering the interaction terms (postural tremor X time)
into the GEE models. Coefficients of the interaction terms showed
the differences of the rate of ataxia progression in two groups.
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This approach has been applied extensively to study the progression
of SCAs.28–30
For the genetic modifier analyses, we constructed logistic regression
models. We used the presence or absence of postural tremor as the
outcome variable and the above-mentioned repeat expansion genes as
the predictive variables, after adjusting for age and gender. Since most
of the genes can cause dominant ataxia (except for FXN), we chose the
longer repeat alleles for the genetic modifier analysis.
All statistical analyses were performed using SPSS software (version 23).
Results
Among 315 SCA patients, we found that SCA2 patients most
commonly had postural tremor (27.5%), followed by SCA6 (16.9%)
and SCA3 (12.4%). Postural tremor was rarely observed in SCA1
patients (5.8%) (Table 1). On the other hand, intention tremor was
present in the majority of SCA patients (78.9%, 97.2%, 79.9%, and
84.5% in SCA1, 2, 3, and 6, respectively). Nearly all SCA patients with
postural tremor also presented with intention tremor, except that one
SCA3 patient with postural tremor did not have intention tremor
(Supplemental Table 1).
We compared the basic demographics between SCA patients with
and without postural tremor. SCA3 patients with postural tremor had
higher CAG repeat expansion numbers than SCA3 patients without
postural tremor (73.7 ¡ 3.1 vs. 70.4 ¡ 4.0, p 5 0.003). CAG repeat
expansion length did not differ in SCA1, 2, 6 patients with and without
postural tremor. Moreover, there were no differences in age of onset,
gender, disease duration, and baseline SARA scores between SCA1,
2, 3, and 6 patients with and without postural tremor (Table 2).
Next, we studied whether SCA patients with postural tremor had
different ataxia progression than those without postural tremor, taking
into account age, gender, and CAG repeat expansions. While CAG
repeat expansions had a strong influence on the rate of ataxia
progression across all SCAs in these models, the presence of postural
tremor had diverse effects on ataxia progression in different SCAs.
In SCA1 and SCA6 patients, the presence of postural tremor predicted
slower ataxia progression (SCA1 b 5 –0.91, p , 0.001; SCA6
b 5 –1.28, p , 0.025). On the other hand, SCA2 patients with postural
tremor had faster ataxia progression (b 5 1.54, p , 0.034). Finally, the
presence of postural tremor did not affect ataxia progression in SCA3
patients (Table 3).
In addition, we studied whether other ataxia-related repeat
expansion genes could influence the clinical presentations of postural
tremor in SCAs. We found that longer repeat alleles of the ATXN1 and
ATXN3 genes were associated with a lower and higher likelihood,
respectively, of postural tremor in SCA2 patients (ATXN1 b 5 –1.53,
p 5 0.037; ATXN3 b 5 0.57, p 5 0.018). In SCA3 patients, longer
repeat alleles in TBP were associated with a higher likelihood of
postural tremor, while longer repeat alleles in PPP2R2B were associated
with a lower likelihood of postural tremor (TBP b 5 0.63, p 5 0.041;
PPP2R2B b 5 -0.40, p 5 0.032). The repeat expansions in other ataxic
genes did not play significant roles in postural tremor in SCA1 and SCA6
patients in our models (Table 4).
Discussion
In the current study, we found that among SCAs, SCA2 patients
most commonly have postural tremor. We also observed that the
presence of postural tremor might predict ataxia progression in
different SCAs. Finally, the disease-causing gene itself, as observed
in SCA3, and the interactions between different ataxic genes, as seen
in SCA2 and SCA3, can play important roles in the clinical features
of SCAs.
The underlying brain circuitry of postural tremor in SCAs is not
completely understood. The majority of SCA patients have intention
tremor, while only a small subset of SCA patients have postural tremor,
suggesting different brain circuitries involved in these two forms of
action tremor. The prototypical disorder of postural tremor is ET,4
which shares some pathological features with SCAs in terms of cere-
bellar degeneration.31–33 Loss of Purkinje cell (PC) and PC axonal
torpedoes has been observed both in ET and SCA cases, although ET
cases have a much milder degree of pathological alterations than SCA
cases.31–33 Olivocerebellar involvement has long been postulated to be
involved in postural tremor in ET.34,35 Olivary neurons send their
axons into the cerebellar cortex to form climbing fibers (CFs) that
innervate PCs, and overactivation of CFs by a compound called
harmaline could induce ET-like tremor in rodents.34,36 Interestingly,
both ET and SCA cases have morphological alterations in CFs.31
Specifically, both ET and SCA cases have decreased CF synaptic
density.31 However, ET cases have CFs extending into the parallel
fiber synaptic territory on PC dendrites, whereas SCA cases have
regressed CFs.31,37–39 It is possible that differential involvement of PCs
Table 1. Baseline Neurological Features of 315 Participants in the Different Subtypes of SCA
Variables, n (%) SCA1, n 5 52 SCA2, n 5 69 SCA3, n 5 129 SCA6, n 5 65 p1
Postural tremor 0.006
No 49 (94.2) 50 (72.5) 113 (87.6) 54 (83.1)
Yes 3 (5.8) 19 (27.5) 16 (12.4) 11 (16.9)
Abbreviations: SCA 5 Spinocerebellar Ataxias.
The value in bold represents statistical significance.
1Chi-square test.
Postural Tremor and Ataxia Progression Gan SR, Wang J, Figueroa KP, et al
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services3
and CFs during the degenerative process of SCAs produces postural
tremor.40 Thus, postural tremor could serve as an indicator of under-
lying pathology.
However, studies also showed that the inferior olive might not be
involved in ET,41,42 and postural tremor could be generated by
gabaergic dysfunction of the cerebellar dentate nucleus and thalamus
within the cerebellothalamocortical circuit.43,44 Interestingly, the thalamus
is preferentially affected in SCA2 patients, which could explain the higher
occurrence of postural tremor in SCA2.45–47
Although SCAs are monogenetic disorders with complete pene-
trance,7,48 we are just beginning to understand the genetic interactions
between different repeat expanded genes in these ataxic disorders.
Interestingly, proteins from the ataxia-causing genes could form
complex interaction networks to govern proper cerebellar physiology
and function.49,50 The interaction between ataxia genes has been
found to influence the age of ataxia onset in SCA patients.51 Our study
further highlights that this interaction between ataxia genes can
additionally affect the clinical presentations in SCA patients.
Our study has several strengths. First, our study is based on the
largest cohort of SCA patients in North America with a longitudinal
follow-up. Therefore, we could adequately address whether SCA
patients with postural tremor have a different clinical progression.
Second, we comprehensively studied the genetic modifiers in a panel of
repeat expansion genes, which allowed us to uncover the interactions
between ataxia genes. However, our study also has several limitations.
First, our sample size remained modest, making our study more prone
to type 2 errors. In particular, we only had three SCA1 patients with
postural tremor. Nonetheless, a sample size of 49 in each group is
able to detect the difference in the prevalence of postural tremor in
our current study between SCA2 (27.5%) and SCA1 (5.8%), at the
significance level of 0.05 and with 80% power.52 Although all four
types of SCAs in our study had a sample size above this threshold,
our sample size is not sufficient to detect more subtle differences.
Therefore, the current study should be considered exploratory, and
a future study with a larger sample size and a longer follow-up is
required. Second, only a baseline measurement was made of postural
tremor, which can change during the disease progression. This issue
should be taken into account in future studies. Third, we did not
obtain inter-rater reliability or formal rater training for tremor
assessment; nonetheless, the raters are all experts specialized in ataxia
and movement disorders. Moreover, the prevalence of postural tremor
in SCAs in the current study is similar to a previous study.21 Fourth,
we did not capture the severity of postural tremor, which could be
measured by the Glass Scale.53 Fifth, we did not perform neuro-
physiological studies to characterize postural tremor in each of the
SCAs, which could provide further insight into the tremor mechanism
by comparing postural tremor in SCAs with that in ET and/or
enhanced physiological tremor. This would advance our under-
standing of whether postural tremor in SCAs is central neurogenic
tremor or is related to abnormal mechanical reflex oscillations.54 Sixth,
medications can be confounding factors and may be tremorigenic,
the effects of which we did not analyze in detail. Nonetheless, we
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previously reviewed medication use in this SCA cohort and found that
five medications were most commonly used (coq10, statins, vitamin E,
riluzole, and varenicline),28 none of which is associated with tremor.
Seventh, we did not record tremor in the head, voice, or face.
However, these types of tremor were uncommon among SCAs, except
for ataxia with vitamin E deficiency, which is often associated with
head tremor.55 Finally, we only focused on the repeat expansion in
selected ataxia genes in the genetic modifier analyses. Variants in other
ataxia genes, along with expansions of the FMR1 gene, might also play
a role, which requires further exploration.
Table 3. Longitudinal SARA Scores of the Different Neurological Symptoms in the GEE Model
Variables Regression Coefficients of SARA Score1
SCA1 SCA2 SCA3 SCA6
Age of first visit (years) 0.62 (,0.001) 0.41 (,0.001) 0.58 (,0.001) 0.37 (,0.001)
Gender2 4.61 (0.013) –0.98 –0.78 –1.80
CAG repeat (numbers) 1.57 (,0.001) 1.79 (,0.001) 1.51 (,0.001) 2.06 (,0.001)
Postural tremor3 –3.66 2.25 1.44 6.04 (,0.001)
Visit time 1.01 (,0.001) 0.20 0.38 (0.025) 1.58 (,0.001)
Postural tremor 6 visit time –0.91 (,0.001) 1.54 (0.034) –0.22 –1.28 (0.025)
Abbreviations: SARA 5 Scale for Assessment and Rating of Ataxia; GEE 5 Generalized Estimating Equation; SCA 5 Spinocerebellar Ataxia.
1All regression coefficients and p-values were calculated in the GEE model, adjusting for age of first visit, gender, CAG repeat, neurological
symptom, and neurological symptom 6 visit time.
2Men 5 0, Women 5 1
3No postural tremor 5 0; postural tremor 5 1.
Table 4. Logistic Regression Analyses for Influencing Factors of Postural Tremor in the Different Subtypes of SCA
Variables Dependent Variable: Postural Tremor
SCA1 SCA2 SCA3 SCA6
b OR p b OR p b OR p b OR p
Age of first visit (years) –1.51 0.22 0.999 0.12 1.13 0.139 0.04 1.04 0.450 –0.02 0.99 0.697
Gender1 –28.29 0.00 0.999 –2.28 0.10 0.077 0.40 1.49 0.632 2.09 8.07 0.032
ATXN1 (SCA1) repeat numbers –0.54 0.58 1.000 –1.53 0.22 0.037 0.14 1.16 0.518 0.34 1.41 0.231
ATXN2 (SCA2) repeat numbers –13.02 0.00 0.999 0.45 1.57 0.205 –0.07 0.93 0.853 –0.53 0.59 0.454
ATXN3 (SCA3) repeat numbers –0.26 0.78 1.000 0.57 1.76 0.018 0.23 1.26 0.177 –0.09 0.92 0.524
CACNA1A (SCA6) repeat numbers 3.59 36.07 1.000 1.80 6.07 0.063 0.03 1.03 0.944 0.66 1.93 0.141
ATXN7 (SCA7) repeat numbers –0.06 0.94 1.000 –0.71 0.49 0.265 0.11 1.12 0.723 0.08 1.09 0.850
ATXN10 (SCA10) repeat numbers –1.71 0.18 1.000 –0.53 0.59 0.144 0.00 1.00 0.996 –0.25 0.78 0.370
PPP2R2B (SCA12) repeat numbers –9.07 0.00 0.998 0.21 1.24 0.343 –0.40 0.67 0.032 0.05 1.05 0.740
TBP (SCA17) repeat numbers –14.51 0.00 0.999 0.09 1.09 0.841 0.63 1.87 0.041 –0.44 0.64 0.353
FXN (FA) repeat numbers 0.26 1.29 1.000 0.06 1.06 0.617 0.04 1.04 0.562 –0.08 0.93 0.417
The values in bold represent statistical significance.
1Men 5 0, Women 5 1.
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In conclusion, our study indicates that postural tremor could be
present in the four most common SCAs and that SCA patients with
postural tremor might have a different rate of ataxia progression.
Genetic interactions between ataxia genes might influence the brain
circuitry involved and thus affect the clinical presentation of postural
tremor.
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